Measurement of adenosine levels in blood and tissue samples from DMD subjects is necessary to directly address the involvement of adenosinergic mechanisms in effects mediated by CD8/CD26 T cells. The gene discussed is DPP4; the disease is Duchenne muscular dystrophy.